Labiana Health, S.A.

€5.05As of Sun 8 Nov 2026, 12:00 UTC
BME:LABHealthcare
Country Spain
PE (Fwd) •••
TSR 4Y CAGR 1.80%
Div yield —
ROE 69.73%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.64
PE TTM 13.82
TSR TTM 16.70%
Mkt cap €41.91M
ROIC 20.43%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€6.21
23.03%
42.86%
Hold 5|8|4|3|8
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.07
0.07
0.07
0.07
29.77%
18.54%
14.13%
12.43%
Revenue€M
4.643
4.760
4.640
4.725
3.35%
0.41%
(1.69%)
2.01%
Peers (US$47.06M)
Cap (US$)
PE
115.7M
25.56x
46.63M
2.890x
Capital
TTM
5Y
10Y
Leveragex
0.103
(2.245)
(2.293)
EBIT/Intx
0.812
1.985
1.989
Own earn%
(85.79)
8.50
0.27
Sh yield%
26.60
17.81
18.10
Owners
Insiders/Inst%
2.95
64.75
Short interest%
0.75
SBC / revenue%
2.36
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
17–26
$1 testx
—
Incr. ROIC%
0